Why the U.S. Still Bleeds Horseshoe Crabs Despite a Lab-Made Alternative

AI justification

U.S. regulatory and industry failure to adopt ethical alternatives causes measurable ecological harm. | The U.S. refusal to adopt synthetic alternatives to horseshoe crab blood for pharmaceutical testing represents a clear ethical failure, prioritizing short-term convenience over animal welfare, ecological sustainability, and public health safety. While Europe’s adoption of synthetic alternatives demonstrates a positive trajectory, the U.S. lags behind despite known harms, creating a net negativ